Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Circulating DNA as a Biomarker of Residual Disease After Chemoradiotherapy for Locally Advanced Head and Necksquamous Cell Carcinoma

NCT07178847 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.

NCT NCT07178847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07178847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Circulating DNA as a Biomarker of Residual Disease After Chemoradiotherapy for Locally Advanced Head and Necksquamous Cell Carcinoma
Lead sponsor
Centre Jean Perrin
Phase
Not applicable
Overall status
Recruiting
Start date
October 13, 2025
Completion date
July 31, 2031
Enrollment
59 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced head and neck carcinoma